Study summary · research use only
[The clinico-epidemiological efficacy of thymogen in acute respiratory viral infections in a military collective]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This epidemiological study in a training military unit evaluated the prophylactic use of timogen (a synthetic thymus peptide) against influenza and other acute respiratory infections (ARI). The abstract reports that intranasal and subcutaneous administration of timogen was associated with a considerable reduction in morbidity rate, gravity and duration of ARI, and states that experimental substantiation for its use in ARI prophylaxis in military units was obtained. The authors describe the clinico-epidemiological outcome in favorable terms.
Abstract
This study gathers the results of epidemiological examination in training military unit, making evaluation of prophylactic efficiency of timogen, i.e. synthetic peptide of thymus for flu and other acute respiratory infections (ARI). The high clinico-epidemiological efficiency of timogen was proved in intranasal and subcutaneous administration that had led to a considerable reduction of morbidity rate, gravity and duration of ARI. Experimental substantiation for timogen administration was obtained that proved its efficiency for flu and other ARI prophylaxis in military units.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.